Claudio Chuaqui
Claudio Chuaqui
Syros Pharmaceuticals
Verified email at
Cited by
Cited by
Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein− ligand binding interactions
Z Deng, C Chuaqui, J Singh
Journal of medicinal chemistry 47 (2), 337-344, 2004
Structure-and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR)
RA Ward, MJ Anderton, S Ashton, PA Bethel, M Box, S Butterworth, ...
Journal of medicinal chemistry 56 (17), 7025-7048, 2013
Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)
J Singh, CE Chuaqui, PA Boriack-Sjodin, WC Lee, T Pontz, MJ Corbley, ...
Bioorganic & medicinal chemistry letters 13 (24), 4355-4359, 2003
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
G Akçay, MA Belmonte, B Aquila, C Chuaqui, AW Hird, ML Lamb, ...
Nature chemical biology 12 (11), 931-936, 2016
Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1
J Wu, K Mikule, W Wang, N Su, P Petteruti, F Gharahdaghi, E Code, X Zhu, ...
ACS chemical biology 8 (10), 2201-2208, 2013
Infrared spectrum and potential energy surface of He–CO
CE Chuaqui, RJ Le Roy, ARW McKellar
The Journal of chemical physics 101 (1), 39-61, 1994
Interaction profiles of protein kinase− inhibitor complexes and their application to virtual screening
C Chuaqui, Z Deng, J Singh
Journal of medicinal chemistry 48 (1), 121-133, 2005
SM16, an orally active TGF-β type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model
K Fu, MJ Corbley, L Sun, JE Friedman, F Shan, JL Papadatos, D Costa, ...
Arteriosclerosis, thrombosis, and vascular biology 28 (4), 665-671, 2008
Knowledge-based design of target-focused libraries using protein− ligand interaction constraints
Z Deng, C Chuaqui, J Singh
Journal of medicinal chemistry 49 (2), 490-500, 2006
Structural interaction fingerprints: a new approach to organizing, mining, analyzing, and designing protein–small molecule complexes
J Singh, Z Deng, G Narale, C Chuaqui
Chemical Biology & Drug Design 67 (1), 5-12, 2006
A reliable new potential energy surface for H2–Ar
C Bissonnette, CE Chuaqui, KG Crowell, RJ Le Roy, RJ Wheatley, ...
The Journal of chemical physics 105 (7), 2639-2653, 1996
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors
W McCoull, RD Abrams, E Anderson, K Blades, P Barton, M Box, ...
Journal of Medicinal Chemistry 60 (10), 4386-4402, 2017
Discovery of 1-Methyl-1H-imidazole Derivatives as Potent Jak2 Inhibitors
Q Su, S Ioannidis, C Chuaqui, L Almeida, M Alimzhanov, G Bebernitz, ...
Journal of medicinal chemistry 57 (1), 144-158, 2014
Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinases
T Wang, MA Block, S Cowen, AM Davies, E Devereaux, L Gingipalli, ...
Bioorganic & medicinal chemistry letters 22 (5), 2063-2069, 2012
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo
JE Dowling, M Alimzhanov, L Bao, C Chuaqui, CR Denz, E Jenkins, ...
ACS Medicinal Chemistry Letters 7 (3), 300-305, 2016
Linewidths and shifts of very low temperature CO in He: A challenge for theory or experiment?
M Thachuk, CE Chuaqui, RJ Le Roy
The Journal of chemical physics 105 (10), 4005-4014, 1996
Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screening
B Yang, ML Lamb, T Zhang, EJ Hennessy, G Grewal, L Sha, ...
Journal of medicinal chemistry 57 (23), 9958-9970, 2014
Structure and property based design of pyrazolo [1, 5-a] pyrimidine inhibitors of CK2 kinase with activity in vivo
JE Dowling, M Alimzhanov, L Bao, MH Block, C Chuaqui, EL Cooke, ...
ACS medicinal chemistry letters 4 (8), 800-805, 2013
Structural interaction fingerprint
Z Deng, C Chuaqui, J Singh
US Patent App. 11/206,034, 2007
Discovery of SY-5609: a selective, noncovalent inhibitor of CDK7
JJ Marineau, KB Hamman, S Hu, S Alnemy, J Mihalich, A Kabro, ...
Journal of Medicinal Chemistry 65 (2), 1458-1480, 2021
The system can't perform the operation now. Try again later.
Articles 1–20